Skip to main content
SpringerLink
Log in

Repaglinide

A Viewpoint by Bruce H.R. Wolffenbuttel

  • Adis New Drug Profile
  • Guest Commentary
  • Published:
Drugs & Aging Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. University Hospital, Maastricht, The Netherlands

    Bruce H. R. Wolffenbuttel

Authors
  1. Bruce H. R. Wolffenbuttel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wolffenbuttel, B.H.R. Repaglinide. Drugs & Aging 13, 181 (1998). https://doi.org/10.2165/00002512-199813020-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199813020-00009

Keywords

Search

Navigation